Latest News and Press Releases

On 14 November 2024, the U.S. Centers for Medicare & Medicaid Services (CMS) issued a final Local Coverage Determination (LCD)1 policy regarding skin substitute grafts/cellular and tissue-based...

  Den ordinære generalforsamling i Coloplast A/S afholdestorsdag den 5. december 2024 kl. 15:30på Coloplast A/S’ adresse, Holtedam 3 (Aage Louis-Hansen Auditorium), Humlebæk, Danmark.Indkaldelsen...

The Annual General Meeting of Coloplast A/S will be held onThursday, 5 December 2024 at 3:30 pm CETat the premises of Coloplast A/S, Holtedam 3 in Humlebæk (the Aage Louis-Hansen Auditorium),...

Coloplast A/S - Årsrapport 2023/24 & Vederlagsrapport 2023/24  Organisk vækst på 8% og en overskudsgrad1 på 27% for regnskabsåret 2023/24. Den rapporterede omsætning målt...

Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24 FY 2023/24 organic growth of 8% and 27% EBIT margin1. Reported revenue in DKK grew 10% to DKK 27,030 million. Organic...

2023/24 Årsregnskabsmeddelelse 1. oktober 2023 – 30. september 2024 Coloplast leverede organisk vækst på 8% og en overskudsgrad1 på 26% i 4. kvartal, negativt påvirket af ekstraordinære...

2023/24 Announcement of full-year financial results 1 October 2023 - 30 September 2024 Coloplast delivered Q4 organic growth of 8% and an EBIT margin1 of 26%, which was negatively impacted by...

Coloplast udvider ledelsesteamet Coloplasts bestyrelse har i dag besluttet at udvide selskabets øverste ledelsesteam med omgående virkning. "Vi er trådt ind i det sidste år af vores...

Coloplast expands Executive Leadership Team Today, the Board of Directors have decided to expand the Coloplast Executive Leadership Team (ELT) with immediate effect. “We have...

Tuesday, 5 November 2024 at 11.00 – 12.00 CETIn connection with the publication of Coloplast's interim financial results for FY 2023/24 the company will host a conference call to present the...